Image

Artistic and Movement Activities to Reduce Anxiety in Children With Acute Lymphoblastic Leukemia.

Artistic and Movement Activities to Reduce Anxiety in Children With Acute Lymphoblastic Leukemia.

Recruiting
8-13 years
All
Phase 3

Powered by AI

Overview

The goal of this clinical trial is to evaluate whether a combined artistic and motor activity program can reduce anxiety in children aged 8-13 with acute lymphoblastic leukemia (ALL) undergoing chemotherapy at Children's Cancer Hospital Egypt 57357. The main questions it aims to answer are:

  • Does participation in the program reduce anxiety compared to standard care?
  • Does the program improve psychological well-being, social interaction, and coping during treatment? Researchers will compare an experimental group (receiving the artistic and motor program) with a control group (receiving standard care only) to see if the intervention lowers anxiety scores on the Spence Children's Anxiety Scale.

Participants will:

  • Be randomly assigned to either the experimental or control group.
  • Complete pre- and post-intervention anxiety assessments.

In the experimental group:

  • Attend 16 weekly sessions over 4 months.
  • Participate in art workshops (drawing, coloring, group activities).
  • Engage in motor activities (warm-up, progressive exercises, relaxation, light games, treadmill/cycling up to 5 minutes).

In the control group:

Will not be exposed to the program, with anxiety measured before and after the same period.

Eligibility

Inclusion Criteria:

  • Age from 8 to 13 years old as recorded in the hospital's official records.
  • Children who experience feelings of anxiety.
  • Medical fitness of the patient (confirmed through medical examination under the supervision of the specialist physician) before implementing the physical abilities program.
  • Being in the third stage of the treatment protocol.

Exclusion Criteria:

  • Cases that are already under follow-up with the psychiatric clinic.
  • Cases that miss 4 sessions of the program.
  • Cases that do not suffer from anxiety.

Study details
    Anxiety
    Acute Leukemia

NCT07878065

Children's Cancer Hospital Egypt 57357

21 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.